openPR Logo
Press release

Valuable Foresights on How Lung (Pulmonary) Airway Disease Treatment Market will Grow During 2017-2027

03-09-2018 06:31 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Valuable Foresights on How Lung (Pulmonary) Airway Disease

Lung (Pulmonary) Airway Disease affects the airways that transport oxygen and other gases in and out of the lungs. The Lung (Pulmonary) Airway Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Lung (Pulmonary) Airway Disease include bronchiectasis, asthma, and COPD. People affected with Lung (Pulmonary) Airway Disease often feel as if they are breathing out through a straw. In Respiratory subdivision of NHLI, the Lung (Pulmonary) Airway Disease shares a prominent share, and it affects significant population in Europe. Chronic obstructive pulmonary disease (COPD) is a kind of obstructive lung disease that affects the airflow for a longer period with shortness of breath and sputum production.

Global Lung (Pulmonary) Airway Disease Treatment Market: Dynamics

The key driver to the Lung (Pulmonary) Airway Disease treatment market is the rising prevalence of respiratory diseases such as asthma, cystic fibrosis, and COPD is increasing significantly across the world and. This is primarily because older adults are highly susceptible to respiratory diseases (COPD, asthma, emphysema) due to reduced immunity and blood flow. Furthermore, introduction of advanced imaging technologies such as digital radiography and computed radiography are other major drivers of the market; this is because these technologies render high-quality digital images. Digital imaging systems have witnessed low adoption rate as these are more expensive than analog imaging systems, this can restrain the Lung (Pulmonary) Airway Disease treatment market.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-4359

Global Lung (Pulmonary) Airway Disease Treatment Market: Segmentation

On the basis of Type, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into,

Asthma
Chronic Obstructive Pulmonary Disorder
Bronchiectasis

On the basis of treatment, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into

Bronchodilators
Corticosteroids
Cytotoxic Drugs
Oxygen Therapy
Antibiotics
Others

On the basis of end-user, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into,

Hospitals
Clinics
ASC’s
Rehabilitation Centers
Others

On the basis of Region, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into,

North America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Latin America
Middle East & Africa

Global Lung (Pulmonary) Airway Disease Treatment Market: Region-wise Outlook

Geographically, North America was the largest market for Lung (Pulmonary) Airway Disease Treatment and the region is anticipated to maintain its dominance during the forecast period. The dominance of North America was due to increasing prevalence of respiratory diseases, rising popularity of portable devices, and growing demand for home health care devices and services. The American Lung Association states that COPD is the third leading cause of death in the U.S. Moreover, rising demand for technologically advanced and innovative products in hospitals, diagnostic laboratories, and outpatient ambulatory surgery centers would fuel market growth in the region. Europe accounted for the second largest share of the global Lung (Pulmonary) Airway Disease Treatment market. However, Asia-Pacific is expected to expand at the highest CAGR during 2016-2024. This growth is mainly attributed to factors such as untapped opportunities, improving health care infrastructure, and increasing awareness about available diagnostic procedures. Rapidly increasing number of hospitals is leading to higher demand for imaging technologies in hospital and laboratory settings, thereby driving the Lung (Pulmonary) Airway Disease Treatment market. Furthermore, the Lung (Pulmonary) Airway Disease Treatment market in Latin America is likely to expand at a significant CAGR. Brazil and Mexico are driving the Lung (Pulmonary) Airway Disease Treatment market in the region due to favorable initiatives were taken by the respective governments. Moreover, rising health care infrastructure would fuel market growth in Latin America.

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4359

Global Lung (Pulmonary) Airway Disease Treatment Market: Key Players

Currently, the global Lung (Pulmonary) Airway Disease Treatment market is highly competitive owing to the involvement of many established players. Some of the key players in the global Lung (Pulmonary) Airway Disease Treatment market are Holaira, Inc., VIDA Diagnostics, Boehringer Ingelheim International GmBH, AstraZeneca, Teva Pharmaceuticals, GlaxoSmithKline, and Novartis.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Valuable Foresights on How Lung (Pulmonary) Airway Disease Treatment Market will Grow During 2017-2027 here

News-ID: 970900 • Views:

More Releases from Future Market Insights

Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered by Advanced Imaging and Office Tech
Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered …
The global polygon mirror scanner motor market is experiencing robust growth, forecasted to rise from USD 55.9 million in 2025 to USD 88.5 million by 2035, which represents a nearly 1.6-fold increase over the assessment period. This remarkable expansion is shaped by the widespread adoption of next-generation scanning technologies and the rapid digital transformation across the printing and office equipment industries. As businesses renew their focus on speed, accuracy, and
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven by Polymer and Textile Demand
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven …
The global p-Hydroxybenzoic Acid (PHBA) market is entering a new era of growth, expected to rise from USD 213.0 million in 2025 to USD 399.8 million by 2035, showcasing a compound annual growth rate of 6.5%. This surge is underpinned by PHBA's flourishing adoption in polymer synthesis, textile processing, and supporting industries seeking high-performance and sustainable chemical solutions. As organizations shift towards advanced materials with enhanced durability, thermal stability, and
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 as Manufacturers Innovate for Green Industries
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 …
The castor oil polyol market is set to reshape the landscape of bio-based chemicals, growing from a value of USD 254.7 million in 2025 to USD 418.8 million by 2035. This represents a robust CAGR of 5.1% over the decade, with expansion driven by surging demand across chemical, automotive, construction, and coatings sectors. The market's early growth, spanning 2021 to 2025, reflects steady adoption as sustainable polyols substitute petroleum-based alternatives,
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smart Fleet Innovations
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smar …
The global Fifth Wheel Coupling Market continues to evolve as the logistics and transport sectors demand more efficient, safe, and smart towing systems. Valued at USD 547.3 million in 2020 and reaching USD 672.6 million by 2024, the market is projected to expand at a 6.0% CAGR from 2025 to 2035, ultimately achieving a valuation of USD 1,238.6 million. At the heart of this growth lies the critical role of fifth

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor